Ester Blanco
Impact in
- Oncology top 10%
- Cancer Immunotherapy and Biomarkers
- CAR-T cell therapy research
- Peptidase Inhibition and Analysis
- Pancreatic and Hepatic Oncology Research
- Immunology top 10%
- Immunotherapy and Immune Responses
- Immune Cell Function and Interaction
- Immune cells in cancer
Papers in
- Oncology 18
- Cancer Immunotherapy and Biomarkers 14
- CAR-T cell therapy research 8
- Pancreatic and Hepatic Oncology Research 4
- Peptidase Inhibition and Analysis 3
- Immunology 14
- Immunotherapy and Immune Responses 9
- Immune Cell Function and Interaction 7
- Immune cells in cancer 4
- Co-authors
- Luisa Chocarro (27 shared papers)David Escors (27 shared papers)Grazyna Kochan (27 shared papers)Ana Bocanegra (23 shared papers)Hugo Arasanz (25 shared papers)Miriam Echaide (22 shared papers)Ruth Vera (13 shared papers)Leticia Fernández (17 shared papers)
- Journals
- International Journal of Molecular Sciences (10 papers)Annals of Oncology (2 papers)Cancers (2 papers)British Journal of Cancer (1 paper)Frontiers in Immunology (1 paper)
- Partner nations
- SpainItalyUnited Kingdom
In The Last Decade
Ester Blanco
30 papers receiving 597 citations
Peers
Comparison fields: 5 of 78
- Oncology 398
- Immunology 302
- Infectious Diseases 59
- Pulmonary and Respiratory Medicine 78
- Cancer Research 29
Countries citing papers authored by Ester Blanco
This map shows the geographic impact of Ester Blanco's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ester Blanco with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ester Blanco more than expected).
Fields of papers citing papers by Ester Blanco
This network shows the impact of papers produced by Ester Blanco. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ester Blanco. The network helps show where Ester Blanco may publish in the future.
Co-authors
The 25 scholars most cited alongside Ester Blanco, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 31 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2021 | 144 | |
| 2 | 2022 | 71 | |
| 3 | 2020 | 69 | |
| 4 | 2022 | 55 | |
| 5 | 2023 | 48 | |
| 6 | 2020 | 27 | |
| 7 | 2022 | 26 | |
| 8 | 2021 | 20 | |
| 9 | 2020 | 19 | |
| 10 | 2022 | 16 | |
| 11 | 2022 | 14 | |
| 12 | 2023 | 13 | |
| 13 | 2022 | 11 | |
| 14 | 2024 | 11 | |
| 15 | 2022 | 11 | |
| 16 | 2023 | 11 | |
| 17 | 2022 | 9 | |
| 18 | 2024 | 9 | |
| 19 | 2022 | 9 | |
| 20 | 2023 | 6 |
About Ester Blanco
Ester Blanco is a scholar working on Oncology, Immunology, Molecular Biology, Infectious Diseases and Epidemiology, having authored 31 papers that have together received 611 indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (14 papers), Immunotherapy and Immune Responses (9 papers), CAR-T cell therapy research (8 papers), Immune Cell Function and Interaction (7 papers), Pancreatic and Hepatic Oncology Research (4 papers), Immune cells in cancer (4 papers), SARS-CoV-2 and COVID-19 Research (3 papers) and Peptidase Inhibition and Analysis (3 papers). The work is most often cited by research in Oncology (398 citations), Immunology (302 citations), Infectious Diseases (59 citations), Pulmonary and Respiratory Medicine (78 citations) and Cancer Research (29 citations). Ester Blanco has collaborated with scholars based in Spain, Italy and United Kingdom. Frequent co-authors include Luisa Chocarro, David Escors, Grazyna Kochan, Ana Bocanegra, Hugo Arasanz, Miriam Echaide, Ruth Vera, Leticia Fernández, Maider Garnica and Pablo Ramos. Their work appears in journals such as International Journal of Molecular Sciences, Annals of Oncology, Cancers, British Journal of Cancer and Frontiers in Immunology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.